RecruitingPhase 4NCT04192656

The Effect of PAP on ISSHL Comorbided With OSA

The Effect of Positive Airway Pressure on Idiopathic Sudden Sensorineural Hearing Loss Comorbided With Obstructive Sleep Apnea: A Clinical Randomized Controlled Study

Sponsor

Beijing Tsinghua Chang Gung Hospital

Enrollment

102 participants

Start Date

Nov 1, 2019

Study Type

INTERVENTIONAL

Conditions

Obstructive Sleep Apnea Sudden Hearing Loss

Summary

This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.

Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ginaton, a drug called Methylprednisolone Hemisuccinate, and others for people with obstructive sleep apnea and sudden hearing loss. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEnon-invasive positive airway pressure

non-invasive positive airway pressure is the first-line treatment for obstructive sleep apnea

DRUGMethylprednisolone Hemisuccinate

Methylprednisolone is the first-line treatment of idiopathic sudden sensorineural hearing loss

DRUGGinaton

ginnaton is ginkgo biloba extract

Locations(1)

Beijing Tsinhgua Changgung Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04192656

Related Trials

Identification of Biomarkers of Obstructive Sleep Apnea.

NCT077231441 location

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

NCT063903455 locations